| Page 185 | Aplastic Anemia and MDS International Foundation

Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.

Author(s): 
Kamio T, Ito E, Ohara A, Kosaka Y, Tsuchida M, Yagasaki H, Mugishima H, Yabe H, Morimoto A, Ohga S, Muramatsu H, Hama A, Kaneko T, Nagasawa M, Kikuta A, Osugi Y, Bessho F, Nakahata T, Tsukimoto I, Kojima S.
Primary Author: 
Kamio T
Journal Title: 
Haematologica
Original Publication Date: 
Mar 2011

Background. Although the

Bone Marrow Diseases: 

Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.

Author(s): 
Pu JJ, Mukhina G, Wang H, Savage WJ, Brodsky RA.
Primary Author: 
Pu JJ
Journal Title: 
Eur J Haematol
Original Publication Date: 
Mar 2011

Objective:  Investigate the natural history of PNH

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

Author(s): 
Marsh JC, Gupta V, Lim Z, Ho AY, Ireland R, Hayden J, Potter V, Koh MB, Islam M, Russell N, Marks DI, Mufti GJ, Pagliuca A.
Primary Author: 
Marsh JC
Journal Title: 
Blood
Original Publication Date: 
Apr 2011

We evaluated a novel

Bone Marrow Diseases: 

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Author(s): 
Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP
Primary Author: 
Afable MG 2nd
Journal Title: 
Blood
Original Publication Date: 
Apr 2011

In

First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.

Author(s): 
Peinemann F, Grouven U, Kröger N, Bartel C, Pittler MH, Lange S
Primary Author: 
Peinemann F
Journal Title: 
PLoS One.
Original Publication Date: 
Apr 2011

INTRODUCTION:

Acquired severe

Bone Marrow Diseases: 

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

Author(s): 
Garg R, Faderl S, Garcia-Manero G, Cortes J, Koller C, Huang X, York S, Pierce S, Brandt M, Beran M, Borthakur G, Kantarjian H, Ravandi F
Primary Author: 
Garg R
Journal Title: 
Leukemia
Original Publication Date: 
Jul 2009

We investigated efficacy and safety of rabbit anti-thymocyte globulin (rATG),